Multiple sclerosis (MS), a disease where the immune system attacks the protective coating of nerves, is increasingly being diagnosed in older adults, a shift from its traditional association with young adulthood. While MS typically affected individuals between 20 and 40, new data indicates a growing proportion of cases are emerging after age 50, with diagnoses in individuals in their 60s more than tripling in some regions.
Neurologists and researchers are exploring a complex interplay of environmental factors and lifestyle choices that may influence the onset of MS. "The trend is real – but we cannot point to one proven reason. It's likely that a combination of factors are at play," said Dr. Rab Nawaz Khan, a UK-based neurologist.
Vitamin D Deficiency and Sunlight Exposure
One significant area of focus is vitamin D deficiency. This nutrient, crucial for immune system regulation, is primarily produced by the body through sunlight exposure. Modern lifestyles, characterized by increased indoor time, consistent sunscreen use, and living in northern latitudes, contribute to low vitamin D levels in a substantial portion of the population, with some studies indicating deficiency in up to two-thirds of adults.
Low vitamin D may compromise the immune system's ability to distinguish between foreign invaders and the body's own tissues, potentially leading to an attack on myelin, the protective sheath around nerve fibers. Studies suggest a link between vitamin D deficiency and a higher risk of developing MS, with some research indicating a 54 percent increased risk. While the exact impact of vitamin D supplementation on prevention is still under investigation, maintaining healthy levels is considered a sensible precaution, particularly for those with a family history of MS.
Obesity's Role in MS Development
Obesity, especially during childhood and adolescence, is identified as a strong risk factor for developing MS later in life. Studies suggest that obesity can roughly double the risk, particularly for women. Fat tissue releases inflammatory proteins, or cytokines, contributing to chronic inflammation that may prime the immune system to attack myelin. Furthermore, obesity is associated with higher levels of leptin, a hormone that promotes inflammation.
Research also indicates that being overweight at the time of diagnosis can accelerate disability progression in individuals with MS. For those diagnosed after age 60, disability has been observed to accumulate rapidly, often necessitating a walking aid within about six years. Encouragingly, weight loss before the onset of MS has been linked to a slower progression of disability.
Smoking as a Key Risk Factor
Smoking remains one of the most significant and well-researched risk factors for MS. Smokers are approximately 50 percent more likely to develop the condition than non-smokers, with some studies showing an even higher risk. The risk increases with the duration and intensity of smoking, and early initiation, particularly before age 15, may heighten vulnerability.
Experts emphasize that avoiding cigarettes is a crucial step in reducing MS risk. At least 13 percent of MS cases could potentially be prevented if individuals did not smoke. Even exposure to secondhand smoke has been associated with an increased risk. Unlike smokeless tobacco, inhaled chemicals in cigarette smoke are considered the likely culprits. Smoking is also linked to more aggressive forms of MS and faster loss of brain tissue.
Viral Infections and Immune System Triggers
The Epstein-Barr virus (EBV), the cause of infectious mononucleosis, is considered a primary environmental risk factor for MS. An estimated 95 percent of Americans are infected with EBV by age 40. Studies have found that individuals infected with EBV are significantly more likely to develop MS compared to those who remain uninfected, with evidence of infection appearing years before diagnosis in most MS patients.
Scientists theorize that EBV may trigger MS through a phenomenon known as molecular mimicry, where certain EBV proteins closely resemble proteins found in myelin. This can lead the immune system to mistakenly attack nerve fibers. Vaccines for EBV are currently under development, though researchers continue to study their potential impact on MS risk.
These factors, acting individually or in concert over decades, are believed to contribute to the observed rise in late-onset MS, underscoring the importance of lifestyle modifications and ongoing research into the disease's complex origins.